跳至主要内容
临床试验/JPRN-UMIN000036788
JPRN-UMIN000036788已完成未知

An investigation of therapeutic efficacy when switching from intensive insulin therapy to long-acting insulin plus either dulaglutide or empagliflozin in type 2 diabetes patients - An investigation of therapeutic efficacy when switching from intensive insulin therapy to long-acting insulin plus either dulaglutide or empagliflozin in type 2 diabetes patients

Chigasaki Municipal Hospital0 个研究点目标入组 60 人开始时间: 2019年5月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with serious hepatic dysfunction 2. Patients with serious renal dysfunction 3. Patients taking steroids 4. Patients with cancer 5. Patients with severe infection or serious injury 6. Patients who are or could be pregnant 7. Patients with an allergy to the drug to be used or for whom it is contraindicated 8. Any other patients considered by the investigator or a subinvestigator to be unsuitable to participate in the study

研究者

相似试验